OBJECTIVE

The aim of this study was to investigate whether carotid intima-media thickness (IMT) and brachial-ankle pulse wave velocity (baPWV) add value to the Framingham risk score (FRS) in predicting the development of cardiovascular diseases (CVDs) in type 2 diabetic patients with a negative history of CVD.

RESEARCH DESIGN AND METHODS

Type 2 diabetic patients (n = 783) were retrospectively recruited and followed for CVD.

RESULTS

During a 5.4-year follow-up period, 85 incidences of CVD were recorded (10.9%). After adjustment for conventional arterial risk factors, multivariate analysis with the Cox proportional hazards model identified IMT, but not baPWV, as a significant determinant of CVD. In addition, the combination of FRS with IMT, but not with baPWV, improved the prediction of CVD.

CONCLUSIONS

Carotid IMT is a significant predictor of CVD in asymptomatic type 2 diabetic patients, and the combination of FRS and IMT improves the prediction of CVD in these patients.

Identification of patients with a high probability of developing cardiovascular diseases (CVDs) is important for efficient treatment of type 2 diabetes. Although the Framingham risk score (FRS) is considered a useful tool for quantitative assessment of the risk for CVD in the general populations (1,2), the score does not have sufficient power to predict future onset of CVD in type 2 diabetic patients (35).

In the current study, we first determined the incidence of CVD in a cohort of patients with type 2 diabetes and then compared the prediction of CVD by FRS alone, the combination of FRS with carotid intima-media thickness (IMT), and the combination of FRS and brachial-ankle pulse wave velocity (baPWV).

Subjects

We screened 1,538 consecutive type 2 diabetic patients (1,025 men and 513 women) who attended Juntendo University Hospital on a regular basis and had undergone a measurement of IMT and baPWV between 2003 and 2005 at the outpatient clinic. Among them, we selected those with the following criteria: 1) diagnosed with type 2 diabetes, 2) 30–75 years of age, and 3) negative history of CVD. Patients with renal dysfunction, severe liver disease, and malignancy were excluded. The hospital ethics committee approved the study protocol, and informed consent was obtained from each subject.

Data acquisition

Blood pressure (BP) and BMI were determined at baseline. Blood samples were obtained after an overnight fast. The 10-year coronary risk was estimated using FRS (6).

CVD, including cardiovascular death, nonfatal myocardial infarction, unstable angina, stable angina, transient ischemic attack, and ischemic stroke, was registered during the 5–6-year follow-up period.

Measurements of IMT and baPWV

The mean IMT of the common carotid artery, including plaque, was measured by ultrasonography using the method described previously (79). baPWV was measured using an automatic waveform analyzer as described previously (8).

Statistical analysis

The baseline data (recorded at study entry) of the different groups were compared by the unpaired Student t test, Mann-Whitney U test, or χ2 test, as appropriate (JMP version 9.0.0; SAS Institute Inc., Tokyo, Japan). Prediction of CVD at the end of the 5–6-year follow-up period was evaluated by comparing receiver operating characteristic (ROC) curves. The cumulative event-free rates were estimated from Kaplan-Meier survival curves and differences were tested by the log-rank test. The Cox proportional hazards model was used to identify independent predictors of primary CVD. Classical atherosclerotic risk factors and markers such as age, sex, BMI, systolic BP, HbA1c, total cholesterol, HDL cholesterol, triglyceride, smoking, baPWV, and carotid artery IMT were assessed as independent variables for modeling. All statistical tests were two-sided with a 5% significance level.

At baseline, 783 patients were recruited for the evaluation. During the follow-up period (5.46 ± 0.39 years), 50 coronary events and 35 strokes were recorded. These patients were older and had higher systolic and diastolic BP, higher baPWV, higher IMT, and higher FRS, compared with those without such events. CVD occurred more frequently in men than in women.

The Kaplan-Meier curves showed lower event-free rates with higher IMT (using the fourth quintile of IMT as the cutoff value; log-rank χ2 = 8.87; P = 0.03), baPWV (using the fourth quintile of baPWV as the cutoff value; log-rank χ2 = 9.83; P = 0.02), and Framingham score (FRS ≤10%, FRS >10% but ≤20%, FRS >20%; log-rank χ2 = 23.1; P > 0.001).

Next, we examined the ability to predict CVD at ∼5 years by evaluating ROC. The areas under the ROC curves for IMT and baPWV were similar (0.590 and 0.583, respectively), although that for FRS was modestly higher (0.645). Simple addition of both IMT and baPWV to FRS results in only a modest increase of the area under the ROC curve (0.656 and 0.655, respectively). Multivariate analysis using the Cox proportional hazards model identified age (relative risk per 1 SD [RR], 1.06; 95% CI 1.03–1.10, P < 0.001), sex (RR for women, 0.50; 0.27–0.92, P = 0.03), and carotid IMT (2.39; 1.19–4.81, P = 0.02) as independent predictors for CVD.

We also investigated whether the combination of FRS and high IMT or baPWV had a greater predictive power for CVD than FRS alone. The Kaplan-Meier curves showed a low cumulative event-free rate with the combination of FRS and IMT (log-rank χ2 = 31.4; P < 0.001), but not with baPWV (log-rank χ2 = 26.2; P < 0.001) (Fig. 1).

Figure 1

CVD event-free rate according to FRS (top), FRS combined with carotid IMT (middle), and FRS combined with baPWV (bottom). Group 0 represents patients with low and intermediate FRS and those with first to third quintile IMT and baPWV values. Group 1 represents patients with high FRS and those with fourth quintile IMT and baPWV values. Categorical variables of 0, 1, and 2 were used for the combined index of carotid IMT plus FRS and FRS plus baPWV.

Figure 1

CVD event-free rate according to FRS (top), FRS combined with carotid IMT (middle), and FRS combined with baPWV (bottom). Group 0 represents patients with low and intermediate FRS and those with first to third quintile IMT and baPWV values. Group 1 represents patients with high FRS and those with fourth quintile IMT and baPWV values. Categorical variables of 0, 1, and 2 were used for the combined index of carotid IMT plus FRS and FRS plus baPWV.

Close modal

The incidence of CVD in type 2 diabetic patients is rising in Japan. In fact, the CVD event rate in our subjects was higher than that reported in a previous study (10). Thus, it is important to identify patients at high risk for developing such events in order to reduce morbidity and mortality.

The estimated cumulative rate of CVD for the highest quintile of IMT and that of baPWV confirmed its relationship with the respective high incidence of primary CVD. Prediction of CVD improved with the combination of FRS and IMT, consistent with a previous small study (11), but not with the combination of FRS and baPWV, compared with FRS alone. In this regard, Nomura et al. (12) reported that carotid IMT, but not baPWV, was an independent determinant of silent cerebral infarction in Japanese type 2 diabetic patients. Another study concluded that IMT was more useful than baPWV for prediction of coronary artery atherosclerosis in patients clinically suspected of having coronary heart disease (13). IMT and baPWV reflect two different aspects of atherosclerosis. Although the exact reason for the difference in their predictive power is not clear at present, IMT seems to have more power in predicting CVD than baPWV. However, further studies of larger sample size are needed.

Our study has certain limitations. First, the study was retrospective and included a relatively small sample size. Second, we evaluated only common carotid IMT including plaque; however, the use of different methods to measure IMT may yield different results.

In conclusion, the current study showed that IMT is an independent risk factor for CVD in asymptomatic type 2 diabetic patients and that the combination of FRS and high IMT, but not baPWV, has a greater predictive power of CVD events compared with FRS alone.

No potential conflicts of interest relevant to this article were reported.

H.W. supervised and planned this work, contributed to the discussion, reviewed and edited the manuscript, and was principal investigator responsible for the contents of the article. M.Y. collected and analyzed data and wrote the manuscript. T.M. supervised and planned this work, contributed to the discussion, and reviewed and edited the manuscript. R.K. reviewed and edited the manuscript. R.Y. analyzed data. T.S., F.I., A.K., and C.O. wrote and reviewed the manuscript. T.H. analyzed the data and supervised this work.

1
D’Agostino
RB
 Sr.
,
Grundy
S
,
Sullivan
LM
,
Wilson
P
;
CHD Risk Prediction Group
.
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation
.
JAMA
2001
;
286
:
180
187
[PubMed]
2
Ramachandran
S
,
French
JM
,
Vanderpump
MP
,
Croft
P
,
Neary
RH
.
Using the Framingham model to predict heart disease in the United Kingdom: retrospective study
.
BMJ
2000
;
320
:
676
677
[PubMed]
3
Coleman
RL
,
Stevens
RJ
,
Retnakaran
R
,
Holman
RR
.
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes
.
Diabetes Care
2007
;
30
:
1292
1293
[PubMed]
4
McEwan
P
,
Williams
JE
,
Griffiths
JD
, et al
.
Evaluating the performance of the Framingham risk equations in a population with diabetes
.
Diabet Med
2004
;
21
:
318
323
[PubMed]
5
van der Heijden
AA
,
Ortegon
MM
,
Niessen
LW
,
Nijpels
G
,
Dekker
JM
.
Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study
.
Diabetes Care
2009
;
32
:
2094
2098
[PubMed]
6
Wilson
PW
,
D’Agostino
RB
,
Levy
D
,
Belanger
AM
,
Silbershatz
H
,
Kannel
WB
.
Prediction of coronary heart disease using risk factor categories
.
Circulation
1998
;
97
:
1837
1847
[PubMed]
7
Mita
T
,
Watada
H
,
Shimizu
T
, et al
.
Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control
.
Arterioscler Thromb Vasc Biol
2007
;
27
:
2456
2462
[PubMed]
8
Mita
T
,
Watada
H
,
Ogihara
T
, et al
.
Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes
.
Atherosclerosis
2007
;
191
:
162
167
[PubMed]
9
Mita
T
,
Watada
H
,
Uchino
H
, et al
.
Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus
.
Endocr J
2006
;
53
:
693
698
[PubMed]
10
Fujishima
M
,
Kiyohara
Y
,
Kato
I
, et al
.
Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study
.
Diabetes
1996
;
45
(
Suppl. 3
):
S14
S16
[PubMed]
11
Bernard
S
,
Sérusclat
A
,
Targe
F
, et al
.
Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects
.
Diabetes Care
2005
;
28
:
1158
1162
[PubMed]
12
Nomura
K
,
Hamamoto
Y
,
Takahara
S
, et al
.
Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes
.
Diabetes Care
2010
;
33
:
168
170
[PubMed]
13
Matsushima
Y
,
Kawano
H
,
Koide
Y
, et al
.
Relationship of carotid intima-media thickness, pulse wave velocity, and ankle brachial index to the severity of coronary artery atherosclerosis
.
Clin Cardiol
2004
;
27
:
629
634
[PubMed]
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.